A Look At The Intrinsic Value Of ALPEK, S.A.B. de C.V. (BMV:ALPEKA)
Key Insights
- ALPEK. de's estimated fair value is Mex$12.39 based on 2 Stage Free Cash Flow to Equity
- ALPEK. de's Mex$14.16 share price indicates it is trading at similar levels as its fair value estimate
- Analyst price target for ALPEK A is Mex$19.36, which is 56% above our fair value estimate
Does the June share price for ALPEK, S.A.B. de C.V. (BMV:ALPEKA) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the forecast future cash flows of the company and discounting them back to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward.
We generally believe that a company's value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.
View our latest analysis for ALPEK. de
The Method
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
10-year free cash flow (FCF) estimate
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (MX$, Millions) | Mex$3.07b | Mex$4.51b | Mex$5.26b | Mex$4.46b | Mex$4.08b | Mex$3.94b | Mex$3.93b | Mex$4.02b | Mex$4.18b | Mex$4.39b |
Growth Rate Estimate Source | Analyst x2 | Analyst x2 | Analyst x2 | Est @ -15.33% | Est @ -8.40% | Est @ -3.55% | Est @ -0.15% | Est @ 2.23% | Est @ 3.90% | Est @ 5.06% |
Present Value (MX$, Millions) Discounted @ 19% | Mex$2.6k | Mex$3.2k | Mex$3.2k | Mex$2.2k | Mex$1.7k | Mex$1.4k | Mex$1.2k | Mex$1.0k | Mex$896 | Mex$794 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = Mex$18b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (7.8%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 19%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = Mex$4.4b× (1 + 7.8%) ÷ (19%– 7.8%) = Mex$44b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= Mex$44b÷ ( 1 + 19%)10= Mex$7.9b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is Mex$26b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of Mex$14.2, the company appears around fair value at the time of writing. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
Important Assumptions
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at ALPEK. de as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 19%, which is based on a levered beta of 1.472. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for ALPEK. de
- Debt is well covered by cash flow.
- Dividend is in the top 25% of dividend payers in the market.
- Interest payments on debt are not well covered.
- Expected to breakeven next year.
- Has sufficient cash runway for more than 3 years based on current free cash flows.
- Good value based on P/S ratio compared to estimated Fair P/S ratio.
- Dividends are not covered by earnings.
- Revenue is forecast to decrease over the next 2 years.
Looking Ahead:
Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For ALPEK. de, we've put together three essential aspects you should look at:
- Risks: Be aware that ALPEK. de is showing 3 warning signs in our investment analysis , and 2 of those are a bit concerning...
- Future Earnings: How does ALPEK A's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the BMV every day. If you want to find the calculation for other stocks just search here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About BMV:ALPEK A
ALPEK. de
Alpek, S.A.B. de C.V., together with its subsidiaries, operates as a petrochemical company in Mexico and internationally.
Undervalued with adequate balance sheet.